[go: up one dir, main page]

SE7613536L - Sett att framstella 3,4-disubstituerade 2-(beta-naftyl-oxi)-etylpyrazoloner och anvendning derav som lekemedel - Google Patents

Sett att framstella 3,4-disubstituerade 2-(beta-naftyl-oxi)-etylpyrazoloner och anvendning derav som lekemedel

Info

Publication number
SE7613536L
SE7613536L SE7613536A SE7613536A SE7613536L SE 7613536 L SE7613536 L SE 7613536L SE 7613536 A SE7613536 A SE 7613536A SE 7613536 A SE7613536 A SE 7613536A SE 7613536 L SE7613536 L SE 7613536L
Authority
SE
Sweden
Prior art keywords
ethylpyrazolones
naphtyl
oxi
disubstituted
medicines
Prior art date
Application number
SE7613536A
Other languages
English (en)
Swedish (sv)
Inventor
E Moller
K-A Meng
F Seuter
H Horstmann
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of SE7613536L publication Critical patent/SE7613536L/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/28—Two oxygen or sulfur atoms
    • C07D231/30—Two oxygen or sulfur atoms attached in positions 3 and 5
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18—One oxygen or sulfur atom
    • C07D231/20—One oxygen atom attached in position 3 or 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/28—Two oxygen or sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE7613536A 1975-12-05 1976-12-02 Sett att framstella 3,4-disubstituerade 2-(beta-naftyl-oxi)-etylpyrazoloner och anvendning derav som lekemedel SE7613536L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19752554701 DE2554701A1 (de) 1975-12-05 1975-12-05 3,4-disubstituierte 2-(beta-naphthyloxy)-aethylpyrazolone

Publications (1)

Publication Number Publication Date
SE7613536L true SE7613536L (sv) 1977-06-06

Family

ID=5963526

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7613536A SE7613536L (sv) 1975-12-05 1976-12-02 Sett att framstella 3,4-disubstituerade 2-(beta-naftyl-oxi)-etylpyrazoloner och anvendning derav som lekemedel

Country Status (9)

Country Link
JP (1) JPS5271467A (xx)
BE (1) BE849047A (xx)
DE (1) DE2554701A1 (xx)
DK (1) DK545676A (xx)
ES (1) ES453908A1 (xx)
FR (1) FR2333505A1 (xx)
LU (1) LU76328A1 (xx)
NL (1) NL7613451A (xx)
SE (1) SE7613536L (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3432062A1 (de) * 1984-08-31 1986-03-06 Bayer Ag, 5090 Leverkusen Pyrazoldionderivate und ihre anwendung bei der bekaempfung von krankheiten
JP3994453B2 (ja) * 1995-10-13 2007-10-17 日産化学工業株式会社 ピラゾロン類
CN104945294B (zh) * 2014-03-31 2016-09-07 中国科学院上海有机化学研究所 含三氟甲硫基的化合物及其制备方法
CN104974065A (zh) * 2015-06-15 2015-10-14 华东理工大学 一种制备α-三氟甲硫基化酮类化合物的方法

Also Published As

Publication number Publication date
ES453908A1 (es) 1977-11-16
FR2333505A1 (fr) 1977-07-01
BE849047A (fr) 1977-06-03
JPS5271467A (en) 1977-06-14
NL7613451A (nl) 1977-06-07
DE2554701A1 (de) 1977-06-08
LU76328A1 (xx) 1977-11-21
DK545676A (da) 1977-06-06

Similar Documents

Publication Publication Date Title
SE7602317L (sv) 1,4-dihydropyridinkarbonsyraalkylestrar till anvendning som lekemedel och sett att framstella desamma
SE7601257L (sv) Bensoylureido-difenyletrar till anvendning som insekticider och sett att framstella dessa
AT345960B (de) Chirurgische gesichtsmaske
SE7607825L (sv) 2,4-diklor-4'-bensoylureido-difenyletrar till anvendning som insekticider och sett for deras framstellning
SE7601258L (sv) Bensoylureido-nitro-difenyletrar till anvendning som insekticider och sett att framstella dessa
DK508479A (da) Derivater af 1-phenyl-3-(4-piperidyl)-1-propanon,der er anvendelige som laegemidler
RO75777A (ro) Procedeu pentru prepararea unor 1,2-benzizotiazolin-3-one
SE7608479L (sv) 4,5-dihydro-2-legre alkoxikarbonylamino-4-fenylimidazoler och substituerade fenylderivat derav och sett att framstella dessa foreningar
SE7513011L (sv) Sett att framstella n-(trimetoxi-3,4,5-cinnamoyl)-piperazin och anvendning derav som lekemedel
SE7604475L (sv) Forfarande for framstellning av 1,1,1-triaryl-alkylaminer
SE7703974L (sv) 1,3,4-tiadiazolylderivat till anvendning som herbicider och sett att framstella foreningarna
SE7708621L (sv) 2-bensyl-pyrrolidiner, sett for framstellning derav och anvendning derav som lekemedel
SE7810142L (sv) Nya tiopropionamider och sett att framstella desamma samt farmaceutiska kompositioner, innehallande foreningarna
SE7602135L (sv) L-3-(3,4-dihydroxi-fenyl)-2-metyl-alanin-peptider
MC1153A1 (fr) N-(1'-allyl 2'-pyrrolidylmethyl)2,3-dimethoxy 5-sulfamoyl benzamide,ses derives
SE7613536L (sv) Sett att framstella 3,4-disubstituerade 2-(beta-naftyl-oxi)-etylpyrazoloner och anvendning derav som lekemedel
FI782220A (fi) Oxadiazol-1,2,4-derivat deras framstaellning och deras anvaendning i medicinvaord
SE428922B (sv) Forfarande for framstellning av 13, 14-dihydro-11-dioxi-prostaglandiner
SE7609971L (sv) N-(1,2,4-triazin-5-on-4-yl)-glycin-derivat, till anvendning som herbicider och sett for deras framstellning
SE7513013L (sv) Sett att framstella 5,7-dihydroxi-tetrahydroisokinolinderivat och anvendning derav som lekemedel
SE7609466L (sv) Nya fenotiazinderivat, anvendning derav som lekemedel och sett for deras framstellning
SE420999B (sv) Framstellning av 2,4-diamino-5-bensylpyrimidiner
SE7900681L (sv) Substituerade trifluormetylbensylkarbamider till anvendning som mellanprodukter for framstellning av kveve-substituerade trifluormetylbensylaminer och sett att framstella karbamiderna
SE7611269L (sv) 2,9-dioxatricyklo-(4,3,1,0,?723,7)-dekaner, mellanprodukter och sett for framstellning derav
SE7513298L (sv) Diaryloxi-imidazolyl-o,n-acetaler till anvendning som lekemedel och sett for deras framstellning